nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—celiac disease	0.0444	0.0495	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—IL23R—celiac disease	0.0428	0.0477	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—IL18RAP—celiac disease	0.0408	0.0455	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL21—celiac disease	0.0346	0.0385	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—MICA—celiac disease	0.0346	0.0385	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—IL15—celiac disease	0.0339	0.0378	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—IL12A—celiac disease	0.0335	0.0373	CbGpPWpGaD
Clenbuterol—TNF—Canonical NF-kappaB pathway—TNFAIP3—celiac disease	0.0269	0.03	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—IL17A—celiac disease	0.0226	0.0252	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.0212	0.0236	CbGpPWpGaD
Clenbuterol—TNF—blood—celiac disease	0.0204	0.198	CbGeAlD
Clenbuterol—NGF—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.0204	0.0227	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TNFRSF25—celiac disease	0.0189	0.0211	CbGpPWpGaD
Clenbuterol—NGF—blood—celiac disease	0.0188	0.183	CbGeAlD
Clenbuterol—ADRB3—connective tissue—celiac disease	0.0174	0.169	CbGeAlD
Clenbuterol—TNF—TGF-beta Receptor Signaling—RUNX3—celiac disease	0.0173	0.0193	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—IL17A—celiac disease	0.017	0.019	CbGpPWpGaD
Clenbuterol—CYP1A2—urine—celiac disease	0.0168	0.163	CbGeAlD
Clenbuterol—TNF—TNF receptor signaling pathway —TNFAIP3—celiac disease	0.0155	0.0172	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—IL10—celiac disease	0.0149	0.0166	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—ETS1—celiac disease	0.0146	0.0163	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—ETS1—celiac disease	0.014	0.0156	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL12A—celiac disease	0.0138	0.0153	CbGpPWpGaD
Clenbuterol—ADRB3—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.0136	0.0151	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—HLA-DRB1—celiac disease	0.012	0.0134	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—celiac disease	0.0117	0.0131	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.0116	0.013	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL12A—celiac disease	0.0112	0.0125	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—CD80—celiac disease	0.0106	0.0118	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—IL10—celiac disease	0.0101	0.0112	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL17A—celiac disease	0.00929	0.0104	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—TNFAIP3—celiac disease	0.00888	0.0099	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL12A—celiac disease	0.00875	0.00976	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DPB1—celiac disease	0.00857	0.00955	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ARHGAP31—celiac disease	0.00856	0.00955	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—CD4—celiac disease	0.00847	0.00944	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CTLA4—celiac disease	0.00812	0.00905	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.00805	0.00898	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.00788	0.00878	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00742	0.00827	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00742	0.00827	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—FCGR2A—celiac disease	0.00742	0.00827	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—celiac disease	0.00721	0.00804	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—MBL2—celiac disease	0.00719	0.00802	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DQA1—celiac disease	0.00715	0.00797	CbGpPWpGaD
Clenbuterol—ADRB1—connective tissue—celiac disease	0.00712	0.0692	CbGeAlD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00676	0.00753	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DQB1—celiac disease	0.00669	0.00746	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—CD4—celiac disease	0.00658	0.00734	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—TNFAIP3—celiac disease	0.00639	0.00712	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL10—celiac disease	0.00632	0.00704	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—CD80—celiac disease	0.00599	0.00668	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00579	0.00646	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00575	0.00641	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYO9B—celiac disease	0.00519	0.00578	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DRB1—celiac disease	0.00509	0.00567	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00492	0.00549	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CD80—celiac disease	0.0047	0.00524	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—CD80—celiac disease	0.00461	0.00514	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TAGAP—celiac disease	0.0045	0.00502	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ARHGAP31—celiac disease	0.00443	0.00494	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCR4—celiac disease	0.00441	0.00492	CbGpPWpGaD
Clenbuterol—CYP1A1—epithelium—celiac disease	0.00436	0.0424	CbGeAlD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00401	0.00447	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00392	0.00437	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—CD80—celiac disease	0.00383	0.00427	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCR3—celiac disease	0.00375	0.00418	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL10—celiac disease	0.00366	0.00409	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00344	0.00383	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00341	0.0038	CbGpPWpGaD
Clenbuterol—CYP1A2—digestive system—celiac disease	0.00336	0.0327	CbGeAlD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00336	0.00375	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RGS1—celiac disease	0.00334	0.00373	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00334	0.00372	CbGpPWpGaD
Clenbuterol—CYP1A1—digestive system—celiac disease	0.00332	0.0322	CbGeAlD
Clenbuterol—ADRB3—GPCR downstream signaling—RGS1—celiac disease	0.00322	0.00359	CbGpPWpGaD
Clenbuterol—CYP1A2—blood—celiac disease	0.00321	0.0311	CbGeAlD
Clenbuterol—CYP1A1—blood—celiac disease	0.00316	0.0307	CbGeAlD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CD80—celiac disease	0.00299	0.00333	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RGS1—celiac disease	0.00293	0.00326	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00292	0.00326	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00286	0.00319	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYO9B—celiac disease	0.00268	0.00299	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ARHGAP31—celiac disease	0.00263	0.00293	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR4—celiac disease	0.00262	0.00292	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR4—celiac disease	0.00258	0.00288	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ARHGAP31—celiac disease	0.00257	0.00287	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR4—celiac disease	0.00256	0.00285	CbGpPWpGaD
Clenbuterol—CYP1A2—liver—celiac disease	0.00251	0.0243	CbGeAlD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR4—celiac disease	0.00249	0.00278	CbGpPWpGaD
Clenbuterol—CYP1A1—liver—celiac disease	0.00247	0.024	CbGeAlD
Clenbuterol—ADRB3—Signaling Pathways—TAGAP—celiac disease	0.00233	0.00259	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR4—celiac disease	0.00226	0.00252	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR3—celiac disease	0.00223	0.00248	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR3—celiac disease	0.0022	0.00245	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR3—celiac disease	0.00218	0.00243	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SH2B3—celiac disease	0.00214	0.00239	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR3—celiac disease	0.00212	0.00236	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR3—celiac disease	0.00192	0.00214	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RGS1—celiac disease	0.00191	0.00213	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RGS1—celiac disease	0.00187	0.00209	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RGS1—celiac disease	0.00174	0.00194	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RGS1—celiac disease	0.00173	0.00193	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RGS1—celiac disease	0.0017	0.0019	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYO9B—celiac disease	0.00159	0.00178	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYO9B—celiac disease	0.00156	0.00174	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LCT—celiac disease	0.00155	0.00173	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR4—celiac disease	0.00148	0.00165	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR4—celiac disease	0.00145	0.00161	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAGAP—celiac disease	0.00138	0.00154	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAGAP—celiac disease	0.00135	0.00151	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR4—celiac disease	0.00134	0.0015	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR4—celiac disease	0.00134	0.00149	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR4—celiac disease	0.00131	0.00146	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR3—celiac disease	0.00126	0.0014	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR3—celiac disease	0.00123	0.00137	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR3—celiac disease	0.00114	0.00127	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR3—celiac disease	0.00114	0.00127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR3—celiac disease	0.00112	0.00125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SH2B3—celiac disease	0.00111	0.00123	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RGS1—celiac disease	0.00103	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RGS1—celiac disease	0.001	0.00112	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CD80—celiac disease	0.00099	0.0011	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LCT—celiac disease	0.000989	0.0011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR4—celiac disease	0.000793	0.000884	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR4—celiac disease	0.000776	0.000865	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR3—celiac disease	0.000675	0.000752	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR3—celiac disease	0.00066	0.000736	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SH2B3—celiac disease	0.000657	0.000733	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SH2B3—celiac disease	0.000643	0.000717	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD80—celiac disease	0.000512	0.000571	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD80—celiac disease	0.000304	0.000339	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD80—celiac disease	0.000297	0.000332	CbGpPWpGaD
